Espen Melum, head of the "Experimental Hepatology" group at the Research Institute of Internal Medicine, under the Division of Surgery, Inflammatory Diseases and Transplantation, was appointed "Researcher of the Month" for March 2018 by the South-Eastern Norway Regional Health Authority (Helse Sør-Øst RHF). Melum's research group studies why inflammation occurs in the bile ducts, which in turn can lead to liver failure. His work is presented in a feature article published on the home page of Helse Sør-Øst.
On the occasion of King Olav V's award 2018 to professor Vessela N. Kristensen there will be held a mini symposium on cancer genomics April 17th at 10am-4pm in the Auditorium at the Institute for Cancer Research, in the K building at Montebello. Speakers are prominent scientists Olga Troyanskaya, Charles Vaske, Sampsa Hautanemi, Diether Lambrechts, Gyan Bhanot, Peter Fasching and Zohar Yakhini.
Professor Harald Stenmark, head of the "Cellular membrane dynamics" group at the Department of Molecular Cell Biology, receives ERC Advanced Grant for the second time. Only two other Norwegian researchers, Professor Edvard Moser (NTNU) and Professor Kenneth Hugdahl (UiB), have received ERC Advanced Grant twice in their careers.
The research project "Coincidence detection of proteins and lipids in regulation of cellular membrane dynamics (CODE)" will last for five years and has been awarded 2.5 million Euro.
The national newspaper VG (Norway's largest news source) presented a research project led by Anne Hansen Ree, Gunhild Mælandsmo, Hege Russnes and Kjersti Flatmark in a comprehensive feature article published on April 2nd, entitled (translated to) "Norwegian researchers with a new breakthrough: Special treatment provides hope for cancer patients".
In a recent publication in Annals of Oncology (journal impact factor 11.9) by Jørgen Smeby and colleagues in the Lothe lab at the Department of Molecular Oncology, integration of gene expression-based subtyping and microsatellite instability status led to discovery of novel subtype-specific prognostic associations of the thoroughly investigated KRAS and BRAFV600E mutations in primary colorectal cancer (CRC).
Professor David Russell has received the prestigious Monrad-Krohns Prize for 2018 for his research contributions on diagnosis and treatment of stroke. "It is a great honor for me and a very important recognition of Norwegian research in cerebrovascular diseases," says the award winner, who is professor at UiO, and senior physician at the Department of Neurology at Oslo University Hospital, where he is heading the "Cerebrovascular diseases" research group.
Jon Amund Kyte, leader of the "Translational cancer immunotherapy" project group at the Department of Cancer Immunology at the Institute for Cancer Research, was appointed "Researcher of the Month" for February 2018 by the South-Eastern Norway Regional Health Authority (Helse Sør-Øst RHF). The group aims to develop improved cancer treatment based on two particularly promising strategies for immunotherapy. This research is presented in a feature article published on the home page of Helse Sør-Øst.
Global Engage has interviewed Guro E. Lind, group leader at the Department of Molecular Oncology.
"In order to achieve gender balance we should focus on why the system is failing recruiting the brilliant young female scientists, rather than discuss what the females should do to increase their chances of a scientific career. It is nothing wrong with our education, skill set or ambitions - it is the system that is flawed"
The Epigenetics Group at the Department of Molecular Oncology, headed by Guro E. Lind, has developed a robust internal control for DNA methylation analyses by droplet digital PCR (ddPCR). The findings have recently been published in the journal Clinical Epigenetics. First author is Heidi Dietrichson Pharo.